Argenx Se (ARGX) Current Assets (2015 - 2025)

Argenx Se (ARGX) posted Current Assets of $6.9 billion for Q4 2025, down 99.88% on a QoQ basis from $5829.7 billion in Q2 2025, and up 41.29% year-over-year from $4.9 billion in Q4 2024.

Argenx Se (ARGX) Current Assets (2015 - 2025) Analysis & Trends

Argenx Se's Current Assets history runs 11 years deep, the most recent figure standing at $6.9 billion for Q4 2025.

  • Quarterly Current Assets rose 41.29% year-over-year to $6.9 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.9 billion (up 41.29% YoY) and the FY2025 annual result came in at $6.9 billion, up 41.29% from the prior year.
  • Current Assets was $6.9 billion for Q4 2025 at Argenx Se, down from $5829.7 billion in the prior quarter.
  • Across five years, Current Assets topped out at $5829.7 billion in Q2 2025 and bottomed at $2.5 billion in Q4 2021.
  • A 5-year average of $586.4 billion and a median of $3.5 billion in 2022 frame the typical range for Current Assets.
  • Annual changes were most pronounced in 2023 — Current Assets slipped 8.12% — and 2025, when it soared 136626.76%.
  • Argenx Se's Current Assets stood at $2.5 billion in 2021, then climbed by 9.09% to $2.8 billion in 2022, then surged by 48.65% to $4.1 billion in 2023, then increased by 18.41% to $4.9 billion in 2024, then jumped by 41.29% to $6.9 billion in 2025.
  • Business Quant data shows ARGX's Current Assets at $6.9 billion in Q4 2025, $5829.7 billion in Q2 2025, and $4.9 billion in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 289.93 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 73.04 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 3.59 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 6.60 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 11.73 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 18.21 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - 521.86 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 1.97 Bn
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 4.22 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 6.90 Bn
Jun 30, 2025 5,829.74 Bn
Dec 31, 2024 4.88 Bn
Jun 30, 2024 4.26 Bn
Dec 31, 2023 4.12 Bn
Jun 30, 2023 2.69 Bn
Dec 31, 2022 2.77 Bn
Jun 30, 2022 2.93 Bn
Dec 31, 2021 2.54 Bn
Jun 30, 2021 2.86 Bn
Dec 31, 2020 2.00 Bn
Jun 30, 2020 2.16 Bn
Dec 31, 2019 1.52 Bn
Jun 30, 2019 1.08 Bn
Dec 31, 2018 653.38 Mn
Jun 30, 2018 424.58 Mn
Dec 31, 2017 431.89 Mn
Jun 30, 2017 200.02 Mn
Dec 31, 2016 109.91 Mn
Dec 31, 2015 48.38 Mn